Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide vs Insulin in Gestational Diabetes
NCT00160485Phase 4Withdrawn
- Sponsor
- Tripler Army Medical Center
- Start
- Jun 2004
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by Tripler Army Medical Center. Planned start Jun 2004; status: withdrawn.
02
Drugs
glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT00160485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160485.